Neoadjuvant Chemotherapy Associated With Improved Survival in High-Risk Nasopharyngeal Carcinoma Patients Treated With Definitive Concurrent Chemoradiation Therapy

Han J.; Yi S. K.; Hsu C. C.

首页> 外文期刊>International Journal of Radiation Oncology, Biology, Physics >Neoadjuvant Chemotherapy Associated With Improved Survival in High-Risk Nasopharyngeal Carcinoma Patients Treated With Definitive Concurrent Chemoradiation Therapy

【24h】

Neoadjuvant Chemotherapy Associated With Improved Survival in High-Risk Nasopharyngeal Carcinoma Patients Treated With Definitive Concurrent Chemoradiation Therapy

机译：Neoadjuvant化疗与高危鼻咽癌患者的提高生存相关，治疗明确的同时的化学疗法治疗

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《International Journal of Radiation Oncology, Biology, Physics》 |2018年第5期|共3页
作者
Han J.; Yi S. K.; Hsu C. C.;
展开▼
作者单位

Univ Arizona Dept Radiat Oncol Tucson AZ 85721 USA;

Univ Arizona Dept Radiat Oncol Tucson AZ 85721 USA;

Univ Arizona Dept Radiat Oncol Tucson AZ 85721 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类放射医学;
关键词

相似文献

外文文献
中文文献
专利

1. Neoadjuvant Chemotherapy Associated With Improved Survival in High-Risk Nasopharyngeal Carcinoma Patients Treated With Definitive Concurrent Chemoradiation Therapy [J] . Han J., Yi S. K., Hsu C. C. International Journal of Radiation Oncology, Biology, Physics . 2018,第5期

机译：Neoadjuvant化疗与高危鼻咽癌患者的提高生存相关，治疗明确的同时的化学疗法治疗
2. Neoadjuvant Chemotherapy (NAC) Associated with Improved Survival in High Risk Nasopharyngeal Carcinoma (NPC) Patients Treated with Definitive Concurrent Chemoradiation Therapy (CCRT) [J] . Han J., Yi S. K., Bearelly S., International Journal of Radiation Oncology, Biology, Physics . 2018,第3Suppla期

机译：Neoadjuvant化疗（NAC）与明确的同时化学疗法治疗（CCRT）治疗的高风险鼻咽癌（NPC）患者提高生存期
3. Neoadjuvant chemotherapy improves survival compared with concurrent chemoradiation alone in nasopharyngeal carcinoma patients with N3 disease [J] . Han James E., Yi Sun K., Wang Steven, Head and neck: Journal for the sciences and specialities of the head and neck . 2019,第12期

机译：Neoadjuvant化疗与单独的N3疾病患者单独的同时脑癌患者同时改善生存
4. CCND1 as a Predictive Biomarker of Neoadjuvant Chemotherapy in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma [C] . Zhien Feng, Lizhen Wang, Bingshun Wang, Academic Committee Conference of Shanghai key lab of stomatology . 2011

机译：CCND1作为局部晚期头颈部鳞状细胞癌患者新辅助化疗的预测生物标志物
5. Symptoms, symptom distress, depressive symptoms, and uncertainty in newly diagnosed head and neck cancer patients receiving definitive radiotherapy with or without chemotherapy [D] . Haisfield-Wolfe, Mary Ellen 2009

机译：新诊断头颈癌患者接受明确放疗并伴或不伴化疗的症状，症状困扰，抑郁症状和不确定性
6. Neoadjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: Defining high-risk patients who may benefit before concurrent chemotherapy combined with intensity-modulated radiotherapy [O] . Xiao-Jing Du, Ling-Long Tang, Lei Chen, -1

机译：局部晚期鼻咽癌的新辅助化疗：确定在并发化疗联合调强放疗前可能受益的高危患者
7. Neoadjuvant Chemotherapy (NAC) Associated with Improved Survival in High Risk Nasopharyngeal Carcinoma (NPC) Patients Treated with Definitive Concurrent Chemoradiation Therapy (CCRT) [O] . J. Han, S.K. Yi, S. Bearelly, 2018

机译：Neoadjuvant化疗（NAC）与明确的同时化学疗法治疗（CCRT）治疗的高风险鼻咽癌（NPC）患者提高生存期

Neoadjuvant Chemotherapy Associated With Improved Survival in High-Risk Nasopharyngeal Carcinoma Patients Treated With Definitive Concurrent Chemoradiation Therapy

著录项

相似文献

相关主题

期刊订阅